Fusen Pharmaceutical Company Limited 

HK$0.98
0
+HK$0+0% 今天

统计数据

当日最高
0.98
当日最低
0.98
52周最高
1.56
52周最低
0.75
成交量
150,000
平均成交量
39,655
市值
993.56M
市盈率
65.5
股息收益率
-
股息
-

股息

0%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
N/A

收益

28May预期
Q1 2018
Q2 2018
Q1 2024
0
0.33
0.67
1
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注1652.HK的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Show more...
首席执行官
Mr. Changcheng Cao
员工
1143
国家
Hong Kong
ISIN
KYG370981030

上市公司